Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: A case-control study

✍ Scribed by Anita S. Patel; Margaret R. Karagas; Michael Pawlita; Tim Waterboer; Heather H. Nelson

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: French
• Weight: 69 KB
• Volume: 122
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.23377

✦ Synopsis

Abstract

The first evidence of an association between HPV and non‐melanoma skin cancer comes from patients with epidermodysplasia verruciformis (EV). EV is a rare heritable disease characterized by cutaneous warts that display not only a high rate of progression to squamous cell carcinoma on sun‐exposed sites, but also a strong predisposition to infection by β‐HPVs, for which HPV 5 and 8 predominate. Two EV genes (EVER1 and EVER2) have been identified, and we tested the hypothesis that variation in the EVER2 gene (rs7208422) is related to seropositivity to HPV (of the genus β types) and risk of squamous cell carcinoma in a population‐based case‐control study of SCC (n = 239 cases and 432 controls). Among controls, variant genotype was associated with β‐HPV seropositvity (OR = 2.3, 95%CI = 1.2–4.3), specifically HPV5 or 8 seropositivity (OR = 2.4, 95%CI = 1.1–5.1) and seropositivity for multiple β‐HPV types (OR = 2.7, 95%CI = 1.1–6.6). Furthermore, variant genotype was also related to SCC risk [adjusted OR for homozygous variant versus homozygous wild type for the EVER2 polymorphism 1.7, 95% CI 1.1–2.7]. These data provide evidence for a role of genetic variation in the EVER2 gene in β‐HPV infection and risk of SCC, shedding light on the link between HPVs and skin cancers. © 2008 Wiley‐Liss, Inc.